A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, August 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 31 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,935 followers.

RT @JaniceM10: A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors. - PubMed - NCBI https://t.co/hM1jG…

A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors. - PubMed - NCBI https://t.co/hM1jG261Fm As always, a team effort brought to fruition.

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.